EXONE Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
EXONE — AI-powered stock analysis, MoonshotScore 50/100.
Last analyzed: Aug 16, 2026EXONE: 1/2 scored disciplines lean bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
EXONE Company Overview
Who Are EXONE's Competitors?
EXONE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DDD 3D Systems Corporation | $3.16 | -7.33% | $516M | — |
| PRLB Proto Labs, Inc. | $78.75 | -4.05% | $1.87B | 80 |
| MTLS Materialise NV | $6.51 | -0.91% | $381M | 49 |
| SLM SLM Corporation | $25.98 | -2.31% | $4.88B | 98 |
| PH Parker-Hannifin Corporation | $1000.13 | -2.26% | $126B | 81 |
| HWM Howmet Aerospace Inc. | $274.75 | -3.08% | $110B | 89 |
| EMR Emerson Electric Co. | $157.61 | -0.11% | $88.3B | 71 |
| CMI Cummins Inc. | $593.46 | -2.45% | $81.9B | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
EXONE Valuation & Market Position
Relative to its peer group, EXONE's quantitative score of 50/100 is below the peer average of 77/100.
EXONE Latest News
No recent news available for EXONE.
EXONE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EXONE.
Price Targets
Wall Street price target analysis for EXONE.
EXONE MoonshotScore
What does this score mean?
The MoonshotScore rates EXONE 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
What Investors Ask About EXONE (EXONE)
What does the AI Score mean for EXONE?
EXONE holds an AI Score of 50/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. EXONE AI Score: 50/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation.
What are the key factors to evaluate for EXONE?
Evaluate EXONE on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does EXONE data refresh on this page?
EXONE prices refresh on page view and on a rolling daily schedule; the last-updated date appears near the top of this page. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven EXONE's recent stock price performance?
EXONE moves on earnings results, analyst revisions, sector rotation, and market sentiment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EXONE overvalued or undervalued right now?
EXONE has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research EXONE before investing?
Before investing in EXONE, research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding EXONE to a portfolio?
No dossier-level strength is on record for EXONE yet — start from the MoonshotScore factor breakdown and the Financials tab on this page. Weigh rewards against risks and diversify. Not financial advice.
Can I buy fractional shares of EXONE?
Yes, most major brokerages offer fractional shares of EXONE with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track EXONE's earnings and financial reports?
EXONE reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for EXONE earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.